Malaria remains a major public health problem, affecting mainly low-and middle-income countries. The management of this parasitic disease is challenged by ever increasing drug resistance. This study, investigated the therapeutic efficacy, tolerability and safety of artemether–lumefantrine (AL) and artesunate–amodiaquine (AS–AQ), used as first-line drugs to treat uncomplicated malaria in Lambaréné, Gabon.
MEASURE Evaluation, a USAID-funded project, is excited to announce the launch of the M&E of Malaria Programs e-course.
M&E of Malaria Programs provides an overview of fundamental concepts of monitoring and evaluation as they specifically relate to malaria prevention and control programs. It provides an overview of: